Evosep Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 62

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $40M

  • Investors
  • 2

Evosep General Information

Description

Developer of clinical proteomics designed to improve quality of life and patient care. The company is developing new technologies and solutions to make sample separation faster and more robust than today's alternatives for clinical and large-scale proteomics, enabling doctors to radically innovate the performance of protein-based clinical diagnostics, initially through collaborations.

Contact Information

Website
www.evosep.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Buchwaldsgade 35
  • Third Floor, Odense C
  • 5000 Odense
  • Denmark
+45 26
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Life Sciences
Corporate Office
  • Buchwaldsgade 35
  • Third Floor, Odense C
  • 5000 Odense
  • Denmark
+45 26

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Evosep Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 09-Jan-2023 $40M Completed Generating Revenue
1. Early Stage VC 30-Jun-2016 Completed Generating Revenue
To view Evosep’s complete valuation and funding history, request access »

Evosep Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Evosep’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Evosep Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Evosep Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3519807-A1 System for subjecting a sample to chromatographic analysis Active 28-Sep-2016
US-20190250130-A1 System for subjecting a sample to chromatographic analysis Pending 28-Sep-2016
EP-3519807-A4 System for subjecting a sample to chromatographic analysis Active 28-Sep-2016
US-20200041467-A1 Chromatographic analysis with low pressure dual gradient refocusing Pending 28-Sep-2016
EP-3519808-A4 Chromatographic analysis with low pressure dual gradient refocusing Active 28-Sep-2016 G01N30/34
To view Evosep’s complete patent history, request access »

Evosep Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evosep Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Novo Holdings Corporate Venture Capital Minority
Denmark's Export and Investment Fund Venture Capital Minority
To view Evosep’s complete investors history, request access »

Evosep Investments (1)

Evosep’s most recent deal was a Early Stage VC with MetaSight. The deal was made on 01-Apr-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MetaSight 01-Apr-2022 Early Stage VC Biotechnology
To view Evosep’s complete investments history, request access »

Ready to get started?

Request a free trial

Evosep FAQs

  • When was Evosep founded?

    Evosep was founded in 2016.

  • Where is Evosep headquartered?

    Evosep is headquartered in Odense, Denmark.

  • What is the size of Evosep?

    Evosep has 62 total employees.

  • What industry is Evosep in?

    Evosep’s primary industry is Biotechnology.

  • Is Evosep a private or public company?

    Evosep is a Private company.

  • What is the current valuation of Evosep?

    The current valuation of Evosep is .

  • What is Evosep’s current revenue?

    The current revenue for Evosep is .

  • How much funding has Evosep raised over time?

    Evosep has raised $46M.

  • Who are Evosep’s investors?

    Novo Holdings and Denmark's Export and Investment Fund have invested in Evosep.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »